TXNIP-IN-1

• Product Name Alternative:

  DDD00107587, EPZ015866; GSK3203591, EPZ015866 (hydrochloride); GSK3203591 (hydrochloride)

• CAS Number:

  1268955-50-5

• UNSPSC Description:

  TXNIP-IN-1 is TXNIP-TRX (thioredoxin-interacting protein- thioredoxin) complex inhibitor extracted from patent US20200085800A1, Compound 1. TXNIP-IN-1 can be used in the research of TXNIP-TRX complex associated metabolic disorder (diabetes), cardiovascular disease, or inflammatory disease[1].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Field of Research:

  Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/txnip-in-1.html

• Purity:

  99.15

• Solubility:

  DMSO : 50 mg/mL (ultrasonic)

• Smiles:

  O=C(O)C(C(C)C)N(C1=O)C(C2=C1C=CN=C2)=O

• Molecular Weight:

  248.238

• References & Citations:

  [1]Rama Natarajan, et al. Txnip-trx complex inhibitors and methods of using the same. US20200085800A1.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  No Development Reported